Neosmart Health closed a €1.2 million seed round from angel investors.

Neosmart Health, a Helsinki, Finland-based company providing software-based preventative healthcare services, announced closing a €1.2 million ($1.3M) seed investment

The round was backed by investors from the Nordics, North America, and Africa, including Sami Laine, Martti Lepistö, Kari Helin, Ahmed Eltigani, Niilo Pellonmaa and Timo Mäkelä.

The funding will be used to start offering the company' services in new markets – Sweden, Estonia, Dubai and start the ground work on expansion to the US, UK, India, China and Japan.

Neosmart Health, founded in 2018 by CEO Marko Nurmela and Pertti Lähteenmäki, combines AI-based software and wearables with traditional medicine to design individualised health optimisation plans for patients. In addition to data-driven tools, patients are paired with Neosmart-licensed doctors at Neosmart’s brick-and-mortar clinics.

The company employs 19 people located in the Helsinki headquarters or the Dubai office, and employed partnerships with the retailer S-Group in Finland, and the Dubai Sports Council and Dubai government.